Amplia Therapeutics Revenue

In the fiscal year ending March 31, 2025, Amplia Therapeutics had annual revenue of 3.78M AUD, down -15.03%. Amplia Therapeutics had revenue of 2.38M in the half year ending March 31, 2025, a decrease of -509.87%.

Revenue

3.78M

Revenue Growth

-15.03%

P/S Ratio

5.84

Revenue / Employee

n/a

Employees

n/a

Market Cap

22.11M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	3.78M	-669.04K	-15.03%
Mar 31, 2024	4.45M	3.26M	274.34%
Mar 31, 2023	1.19M	-793.83K	-40.03%
Mar 31, 2022	1.98M	449.80K	29.33%
Mar 31, 2021	1.53M	1.50M	4,380.44%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
CSL Limited	24.61B
Pro Medicus	184.58M
Cochlear	2.31B
Sonic Healthcare	9.33B
Telix Pharmaceuticals	783.21M
Ramsay Health Care	17.12B
Ansell	3.00B
Mesoblast	9.16M

Revenue Rankings